valsartan banner

Ward Black Law is currently investigating Valsartan cancer claims. Valsartan is a blood pressure medication that was recently recalled by multiple companies because the drug was contaminated with a cancer-causing substance, going back at least four years. The recalls were prompted by the discovery that Valsartan produced in China by Zhejiang Huahai Pharmaceuticals contained a probable carcinogen called N-nitrosodimethylamine (NDMA). 

The Food and Drug Administration (FDA) has received several adverse event reports from patients, and we are investigating Valsartan cancer claims, including:

  • Liver cancer
  • Kidney cancer and renal cancer
  • Stomach cancer
  • Gastrointestinal cancer
  • Metastatic cancer to lungs, colon, brain, pelvic organs

We are also investigating claims for people who paid for Valsartan, without knowing about these manufacturing defects, and claims for people concerned about the risk of cancer in the future.

On July 13, 2018, the FDA advised in a press release that after a careful assessment, the Valsartan-containing medications at issue do not meet the agency’s safety standards and urged companies to take immediate action to protect patients.

Days later, voluntary recalls were initiated by multiple pharmaceutical companies. Most of the companies involved in manufacturing and selling the Valsartan and other potentially affected medications include:

  • Teva Pharmaceuticals
  • Teva Pharmaceuticals USA
  • Major Pharmaceuticals
  • Actavis
  • Prinston Pharmaceuticals
  • Soco Healthcare LLC
  • Torrent Pharmaceutical
  • Camber Pharmaceutical

If you or someone you know has a potential Valsartan claim, contact one of our experienced product liability attorneys today for a free case review. Call or text (336) 333-2244 or (800) 531-9191 or email info@wardblacklaw.com.

GET YOUR CASE REVIEWED AT NO CHARGE